Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/3129
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChaudhary, Sunita A.-
dc.contributor.authorMehta, Tejal A.-
dc.contributor.authorChaudhary, Ankit B.-
dc.date.accessioned2012-04-20T04:53:25Z-
dc.date.available2012-04-20T04:53:25Z-
dc.date.issued2010-
dc.identifier.issn0974-4290-
dc.identifier.urihttp://10.1.7.181:1900/jspui/123456789/3129-
dc.descriptionInternational Journal of ChemTech Research 2(2):1026-1030, 2010.en_US
dc.description.abstractRZT is potent anti migraine drug having agonist activity at the 5-hydroxytryptamine (5-HT) 1B and 5-HT 1D receptor. It commonly used for relief of headaches in treatment of migraine. Conventional tablets of RZT are not capable of rapid action, which is required for immediate relief from migraine pain. Marketed freeze dried tablet of RZT is available. Freeze drying is cumbersome and it yields a fragile and hygroscopic product. Thus, the aim of the present investigation is to formulate orally disintegrating tablets (ODTs) of Rizatriptan using simple and cost effective dosage forms. Approach used was use of superdisintegrants to prepare tablets. Tablets were prepared by direct compression using superdisintegrants such crospovidone, croscarmellose sodium, and sodium starch glycolate with incorporation of diluents like lactose, MCC and mannitol. Tablets of RZT prepared using crospovidone with MCC exhibited the least friability and disintegration time ( s). To decrease the disintegration time further, modified diluents like spray dried lactose, Avicel PH 102 and Orocell 200.used along with the superdisintegrants for the preparation of ODTs. Tablet prepared using orocell showed good disintegration but shows less dispersion. Further trial was done in combinations of Orocell with Avicel PH 102. Among them Avicel PH 102 and orocell in 35:65 ratio showed less time of disintegration and rapid dissolutionen_US
dc.publisherSphinx Knowledge Houseen_US
dc.relation.ispartofseriesIPFP0038en_US
dc.subjectOrally disintegrating tabletsen_US
dc.subjectRizatriptan benzoateen_US
dc.subjectOrocellen_US
dc.subjectFacuty Paperen_US
dc.subjectPharmacy Faculty Paperen_US
dc.titleFormulation, Development and Evaluation of fast disintegrating tablets of Rizatriptan benzoate using novel adjuvantsen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0038.pdfIPFP0038180.58 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.